The Contribution of Flow Cytometry in the Diagnosis and Classification of Lymphomas

Thesis Summary: Evaluation of the Contribution of Flow Cytometry in the Diagnosis and Classification of LymphomasBackground and Clinical Rationale This research, conducted by Dr. Salah Eddine Belakehal at the University of Algiers, addresses a critical diagnostic challenge in hematologic oncology: the precise classification of malignant lymphomas. While histopathology remains the mandatory reference for diagnosis, it frequently encounters limitations when differentiating between lymphoid hyperplasias, Hodgkin’s disease, and metastatic carcinomas. This study establishes Flow Cytometry (FCM) as a pivotal tool to provide a "diagnosis of certainty" by enabling high-resolution immunophenotyping on cellular suspensions.Objectives and Methodology The primary objective of the thesis was to standardize the FCM technique within the Hematology Department for the analysis of lymph node products. The study employed a prospective design, following 129 patients with suspected malignant lymphoma and lymphadenopathy over a 36-month period (2006–2008). The methodology involved two distinct phases:Technical Validation: Initial setup and training using peripheral blood samples.Clinical Application: Transitioning the technique to lymph node cellular suspensions obtained via Fine Needle Aspiration (FNA), , or perfusion and mechanical dilaceration.The technical protocol involved systematic cell washing with PBS, multi-parameter labeling (triple labeling by 2008), and data acquisition of up to 50,000 events using Cell Quest software.Results and Analysis The study population showed a significant male predominance with a sex ratio of 2.7. In cases involving blood analysis ($n=60$), the Matutes Score was utilized as a diagnostic cornerstone for Chronic Lymphocytic Leukemia (CLL), evaluating markers such as CD5, CD23, FMC7, and surface Immunoglobulins. FCM demonstrated clear advantages in:Lineage Determination: Accurately distinguishing between B-cell and T/NK-cell lineages.Diagnostic Reliability: Improving the reliability of malignant lymphoma diagnosis when coupled with traditional cytology and histopathology.Operational Efficiency: Achieving a complete immunophenotypic profile in approximately 3 hours.Conclusion and Clinical Impact The research concludes that the integration of FCM is essential for modernizing the management of hematological malignancies in Algeria. Despite the absence of routine molecular biology or cytogenetics at the time of the study, FCM provided the necessary data for targeted therapy and major prognostic assessments. The study advocates for the systematic use of FCM on lymph node products to ensure precise classification according to WHO standards.Keywords: Flow Cytometry (CMF), Malignant Lymphoma (LNH), Immunophenotyping, Matutes Score, Fine Needle Aspiration, B and T Lineage Differentiation, Hematology, Anatomopathology / Histopathology, Lymph Node Puncture (Adénopathie)